Bill

Bill > SB2960


IL SB2960

IL SB2960
INS-LUNG CANCER & BIOMARKER


summary

Introduced
01/27/2026
In Committee
02/03/2026
Crossed Over
Passed
Dead

Introduced Session

104th General Assembly

Bill Summary

Amends the Illinois Insurance Code. Provides that a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed on or after January 1, 2028 shall provide coverage for medically necessary lung cancer screenings, including any medically necessary tests for lung cancer biomarkers, including, but not limited to, anaplastic lymphoma kinase (ALK). Amends the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, and the Illinois Public Aid Code to require coverage under the provisions of those Acts.

AI Summary

This bill mandates that by January 1, 2028, all group and individual accident and health insurance policies and managed care plans in Illinois must cover medically necessary lung cancer screenings, including tests for lung cancer biomarkers like anaplastic lymphoma kinase (ALK). This requirement extends to various state programs and codes, including those for state employees, counties, municipalities, schools, health maintenance organizations (HMOs), and public aid recipients, ensuring broader access to this type of screening and testing.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Postponed - Insurance (on 02/17/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...